The landscape of managing diabetes is changing with the emergence of GLP-1 patches . These convenient delivery systems offer a likely simpler alternative to needle administrations for individuals living with type 2 diabetes . Such a system deliver a GLP-1 agonist directly through the skin , bypassing the requirement for daily injections and potenti